Who owns Kaopectate?
Kaopectate is owned by Genomma Lab (Mexico, BMV: LAB), which has owned the brand since 2013.[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Key facts
- Current owner
- Genomma Lab Internacional, S.A.B. de C.V. reported
- Owned since
- Previous owner
- None recorded
- Owner HQ
- 🇲🇽 Mexico, Mexico City
- Origin
- 🇺🇸 United States
- Category
- Consumer health › Over-the-counter medicine › Digestive health
- Parent ticker
- BMV: LAB
- Last verified
- · 1 sources
About Kaopectate
Kaopectate is an anti-diarrhoeal suspension that Genomma Lab acquired in 2013 as part of a package of brands bought from Johnson & Johnson with distribution across several Latin American countries. The same package brought it Agarol, Masse, Triatop, Emplastro Sabiá, Bebederm, Carlo Erba and Dulcoryl. The brand is often still assumed to be a Johnson & Johnson product in the markets Genomma took over.
Ownership timeline of Kaopectate
- 2013 – present Genomma Lab [1] reported
Where Kaopectate sits in Genomma Lab
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Genomma Lab ownership tree →
Other brands owned by Genomma Lab in consumer health
Latest news about Kaopectate
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Kaopectate?
The parent company of Kaopectate is Genomma Lab, a publicly listed company headquartered in Mexico.
Is Kaopectate owned by Johnson & Johnson?
No. Kaopectate is owned by Genomma Lab, not Johnson & Johnson.
Is Kaopectate American or Mexican?
Kaopectate originated in the United States, but it is owned today by Genomma Lab, which is headquartered in Mexico. So Kaopectate is an American-origin brand under Mexican ownership.
Since when has Genomma Lab owned Kaopectate?
Genomma Lab has owned Kaopectate since 2013.
Is Kaopectate still owned by Genomma Lab?
Yes. As of 23 September 2026, Kaopectate is still owned by Genomma Lab. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.